Embedded Files
Next MCS SIG webinar speakers
Next MCS SIG webinar speakers
Webinar series will return in 2024.
Webinar series will return in 2024.
Previous MCS SIG webinar speakers
Previous MCS SIG webinar speakers
Veronica Ciocanel Ph.D. Modeling and Topological Data Analysis For Biological Ring Channel Dynamics
Veronica Ciocanel Ph.D. Modeling and Topological Data Analysis For Biological Ring Channel Dynamics
Zackary Kenz Ph.D. (DILISym). Leveraging IPF QSP modeling and simulated patients to build a model of
SSc-ILD
Link to webinar recording
Zackary Kenz Ph.D. (DILISym). Leveraging IPF QSP modeling and simulated patients to build a model of
SSc-ILD
Link to webinar recording
Helen Moore Ph.D., MCS SIG Steering Committee Member. Evaluation Framework for Systems Model
Link to webinar (courtesy of IMAG/MSM Working Group on Multiscale Modeling and Viral Pandemics)
Helen Moore Ph.D., MCS SIG Steering Committee Member. Evaluation Framework for Systems Model
Link to webinar (courtesy of IMAG/MSM Working Group on Multiscale Modeling and Viral Pandemics)
Alison Marsden Ph.D. Cyberinfrastructure for Patient Specific Modeling in Cardiovascular Disease
Alison Marsden Ph.D. Cyberinfrastructure for Patient Specific Modeling in Cardiovascular Disease
Karin Leiderman Ph.D. A Systems Biology Approach to Identifying Modifiers of Bleeding in Hemophilia
Karin Leiderman Ph.D. A Systems Biology Approach to Identifying Modifiers of Bleeding in Hemophilia
Andrea Saltelli Ph.D. How NOT to Do Sensitivity Analysis
Andrea Saltelli Ph.D. How NOT to Do Sensitivity Analysis
Link to slides: http://www.andreasaltelli.eu/file/repository/SA_NOT_ISoP_February_BIS.pdf
Link to the webinar recording: https://us02web.zoom.us/rec/share/dqgKxoUjZJUYhYFtx7GNk7lAzQ330F_DnEvZ-sgAGLtYXZgi7jJlbtHEX_G7MZVl.beygLj2z9zGx5Yfz
Elaine Spiller Ph.D. Sensitivity Analysis: An Introduction and Examples
Elaine Spiller Ph.D. Sensitivity Analysis: An Introduction and Examples
Link to the webinar recording:
Robert J. Bauer Ph.D. Understanding the Methodology and Uses of Some New Features in NONMEM 7.5: Clinical Trial Design Evaluation and Optimization, and Delay Differential Equations.
Robert J. Bauer Ph.D. Understanding the Methodology and Uses of Some New Features in NONMEM 7.5: Clinical Trial Design Evaluation and Optimization, and Delay Differential Equations.
Link to the webinar recording:
https://www.dropbox.com/s/mj5aosp3s37hl1h/NONMEM7.5.mp4?dl=0
Kelly Arnold Ph.D. A Systems Approach to Unravel Personalized Differences in Antibody-Fc Recepter Interactions After Vaccination
Kelly Arnold Ph.D. A Systems Approach to Unravel Personalized Differences in Antibody-Fc Recepter Interactions After Vaccination
Link to the webinar recording:
https://www.dropbox.com/s/cchah49dvjg3tjw/A%20Systems%20approach%20FC%20Receptor.mp4?dl=0
Bree Aldrige Ph.D. Engineering multidrug therapies for tuberculosis using systematic in vitro measurement
Bree Aldrige Ph.D. Engineering multidrug therapies for tuberculosis using systematic in vitro measurement
No recording available
Heiko Enderling Ph.D. Integrating computer modeling into patient-specific radiation oncology decision making
Heiko Enderling Ph.D. Integrating computer modeling into patient-specific radiation oncology decision making
Link to the webinar recording:
https://www.dropbox.com/s/mxxpap18colzrav/isop%20mcs%20sig_heiko%20enderling.mp4?dl=0
Trachette Jackson Ph.D. Mathematical Models of Targeted Cancer Therapeutics
Trachette Jackson Ph.D. Mathematical Models of Targeted Cancer Therapeutics
Link to the webinar recording:
https://www.dropbox.com/s/pepjqz42hmh170v/mcs%20sig%20webinar%20%28sept%29.mp4?dl=0
MCS SIG Update
MCS SIG Update
ACoP 12 (2021) MCS SIG Events
Meet the MCS SIG session: 4pm - 5:30pm Eastern, Nov 10 2021
Featured MCS SIG session: 1pm - 2:30pm Eastern, Nov 11 2021
5B - MCS+: Bringing More Mathematical and Computational Sciences (MCS) into Pharmacometrics
MCS SIG Poster Award:
Niklas Korsbo Automatic identification of non-obvious prognostic factors in big data with DeepNLME
MCS SIG Poster Walk:
Shuhua Hu Implementation of Gamma, Inverse Gamma, and Weibull Absorption Delay Models
Julian Otalvaro The search for initial conditions in Population Pharmacokinetics using a Reinforcement Learning algorithm
Rong Chen RPEM - The Randomized Parametric Expectation Maximization Algorithm
MCS working groups
MCS working groups
The mission of the International Society of Pharmacometrics (ISoP) is the promotion and advancement of the discipline of pharmacometrics, through Integration, Innovation, and Impact
The Division of Biological Physics, established in 1973, is composed of individuals who are interested in the study of biological phenomena using physical approaches and in investigations into the physical principles and mechanisms by which living organisms survive, adapt, and grow. The richness of life science phenomena gives biological physics a very broad scope, from answering fundamental questions about life to advancing the biomedical sciences by developing new drugs and diagnostics equipment.
The Society for Industrial and Applied Mathematics (SIAM) is a multidisicplinary organization of 14,000 members in applied mathematics and computational science. The SIAM Activity Group in the Life Sciences fosters the application of mathematics to the life sciences and research in mathematics that leads to new methods and techniques useful in the life sciences, including drug development. The Life Sciences group has about 850 members and organizes a topical conference in even years.
The Society for Mathematical Biology (SMB) is an international organization of thousands of members that combine mathematical and computational tools to study important open problems in the biological sciences presented in the Bulletin of Mathematical Biology. In addition to yearly meetings there are many award and funding opportunities for members.
The UK QSP Network has been formed by an enthusiastic group of UK and international scientists in industry and academia, to bring and nurture this new emerging area of science to the UK research space. The network is jointly funded by the Engineering and Physical Sciences Research Council (EPSRC) and the Medical Research Council with recognised finanical support from Pfizer, AstraZeneca and GlaxoSmithKline.
Google Sites
Report abuse